MX2020007906A - Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. - Google Patents

Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.

Info

Publication number
MX2020007906A
MX2020007906A MX2020007906A MX2020007906A MX2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A
Authority
MX
Mexico
Prior art keywords
otitis
prevention
treatment
composition
upper respiratory
Prior art date
Application number
MX2020007906A
Other languages
English (en)
Inventor
Quintana Esther Antonia Jiménez
Gómez Juan Miguel Rodríguez
Original Assignee
Probisearch S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probisearch S L U filed Critical Probisearch S L U
Publication of MX2020007906A publication Critical patent/MX2020007906A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Una cepa de Lactobacillus salivarius como producto probiótico, y su uso en el tratamiento y/o la prevención de otitis e infecciones respiratorias de vías altas.
MX2020007906A 2018-01-26 2019-01-25 Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. MX2020007906A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382046.3A EP3517119B1 (en) 2018-01-26 2018-01-26 Composition comprising new lactobacillus salivarius strain and method for the prevention and treatment of otitis and upper respiratory infections
PCT/EP2019/051858 WO2019145476A1 (en) 2018-01-26 2019-01-25 Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections

Publications (1)

Publication Number Publication Date
MX2020007906A true MX2020007906A (es) 2020-10-28

Family

ID=61189392

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007906A MX2020007906A (es) 2018-01-26 2019-01-25 Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.

Country Status (15)

Country Link
US (2) US11406674B2 (es)
EP (1) EP3517119B1 (es)
JP (1) JP2021511822A (es)
AU (1) AU2019211073A1 (es)
BR (1) BR112020015168A2 (es)
CA (1) CA3089366A1 (es)
CL (1) CL2020001958A1 (es)
CO (1) CO2020009424A2 (es)
DK (1) DK3517119T3 (es)
ES (1) ES2898876T3 (es)
MX (1) MX2020007906A (es)
PE (1) PE20210319A1 (es)
PT (1) PT3517119T (es)
RU (1) RU2020125713A (es)
WO (1) WO2019145476A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2360341T3 (es) 1997-02-11 2011-06-03 Enterprise Ireland (Trading As Bioresearch Ireland) Cepas probióticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de las mismas.
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
WO2002016554A1 (fr) 2000-08-25 2002-02-28 Wakamoto Pharmaceutical Co.,Ltd. Produits probiotiques contenant une bacterie de l'acide lactique
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
RU2302458C2 (ru) 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
KR101098946B1 (ko) 2009-07-22 2011-12-28 대한민국 신규한 락토바실러스 살리바리우스 균주 및 이를 함유하는 사료첨가제 조성물
CN102618452B (zh) 2011-02-01 2014-06-25 任发政 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
US9403181B2 (en) * 2013-07-26 2016-08-02 Paul O'Malley Oral care product formulation
WO2015093937A1 (en) 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
CN104095224A (zh) * 2014-06-11 2014-10-15 胡安然 一种防治中耳炎的微生态特殊膳食
US20170333494A1 (en) 2014-11-10 2017-11-23 Glaxosmithkline Intellectual Property Development Limited Probiotic therapeutic applications

Also Published As

Publication number Publication date
CO2020009424A2 (es) 2020-10-30
RU2020125713A (ru) 2022-02-28
EP3517119A1 (en) 2019-07-31
PE20210319A1 (es) 2021-02-16
CL2020001958A1 (es) 2020-12-11
US20220347240A1 (en) 2022-11-03
ES2898876T3 (es) 2022-03-09
PT3517119T (pt) 2021-11-30
BR112020015168A2 (pt) 2020-12-29
CA3089366A1 (en) 2019-08-01
US20210030820A1 (en) 2021-02-04
JP2021511822A (ja) 2021-05-13
US11903983B2 (en) 2024-02-20
WO2019145476A1 (en) 2019-08-01
WO2019145476A8 (en) 2020-10-01
EP3517119B1 (en) 2021-08-11
DK3517119T3 (da) 2021-11-15
AU2019211073A1 (en) 2020-08-20
US11406674B2 (en) 2022-08-09

Similar Documents

Publication Publication Date Title
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
MY186217A (en) Mixture of hmos
NZ777234A (en) Compositions comprising bacterial strains
IL291460A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
PH12019502340A1 (en) Probiotic molecules for reducing pathogen virulence
PL3412766T3 (pl) Szczep lactobacillus salivarius, zawierająca go kompozycja i jego zastosowania
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
IL291445A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
EP3842516A4 (en) NOVEL CUTIBACTERIUM AVIDUM STRAIN AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF ATOPIC DERMATITIS WITH A STRAIN OR CULTURED PRODUCT THEREOF
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
EP4086335A4 (en) LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME
AU2016100865A4 (en) Multi-strain probiotic composition
EP4086334A4 (en) LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
WO2020091179A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
PH12017502042A1 (en) Dietary supplement
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
WO2018004224A3 (ko) 신규 스포리치아과 미생물 및 그의 용도
WO2020091180A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
MX2024008818A (es) Un producto de combinacion util para profilaxis y tratamiento de sindrome de intestino irritable.
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
MX2021004150A (es) Composiciones que comprenden cepas bacterianas.
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.